Literature DB >> 26332735

Psoriasis-like lesions in a patient with familial Mediterranean fever.

Miwa Ashida1, Yuta Koike1, Sayaka Kuwatsuka1, Kunihiro Ichinose2, Kiyoshi Migita3, Shigetoshi Sano4, Atsushi Utani1.   

Abstract

Familial Mediterranean fever (FMF) is a rare hereditary autoinflammatory disorder that is caused by pyrin gene mutation associated with aberrance of the interleukin (IL)-1β pathway and characterized by recurrent, self-limiting attacks of fever and other inflammatory symptoms. We report a case of FMF with annular erythema and psoriasis-like lesions, the latter of which demonstrated parakeratosis with neutrophil microabscesses and mild inflammatory mononuclear cell infiltration in the upper dermis. Immunofluorescence staining showed IL-17-positive T-cells. Skin eruption with neutrophil migration in the epidermis may be provoked by T-helper 17 cell activation through the abnormal IL-1β cascade in FMF.
© 2015 Japanese Dermatological Association.

Entities:  

Keywords:  familial Mediterranean fever; interleukin-17; interleukin-1β; neutrophil; psoriasis-like lesions

Mesh:

Substances:

Year:  2015        PMID: 26332735     DOI: 10.1111/1346-8138.13068

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Increased psoriasis frequency in patients with familial Mediterranean fever.

Authors:  Abdulsamet Erden; Ezgi Deniz Batu; Emrah Seyhoğlu; Alper Sari; Hafize Emine Sönmez; Berkan Armagan; Selcan Demir; Emre Bilgin; Levent Kilic; Omer Karadag; Ali Akdogan; Yelda Bilginer; Ihsan Ertenli; Sedat Kiraz; Sule Apras Bilgen; Umut Kalyoncu
Journal:  Ups J Med Sci       Date:  2018-01-24       Impact factor: 2.384

2.  FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study.

Authors:  Abdulla Watad; Nicola Luigi Bragazzi; Mohammad Adawi; Yehuda Shoenfeld; Doron Comaneshter; Arnon D Cohen; Dennis McGonagle; Howard Amital
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.